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Available online 25 October 2011Dendritic cells (DCs) play a pivotal role in polarising Th lymphocyte subsets but it is unclear
whatmolecular events occurwhenDCs generate Th2-type responses. Here, we analysed plas-
mamembrane-enriched fractions from immature, pro-Th1 and pro-Th2 DCs and used a com-
bination of iTRAQ labelling and LC–MS/MS to quantify changes in the proteomes. Analysis was
performed on triplicate biological samples and changes verified by flow cytometry. MHC class
II molecules and CD29 were up-regulated in pro-Th1 DCs whilst CD18 and CD44 were up-
regulated in pro-Th2 DCs. One of the most down-regulated molecules in pro-Th1 DCs was
YM-1 whilst the greatest decrease in pro-Th2 DCs was NAP-22. Other molecules up-
regulated in pro-Th2 DC compared to pro-Th1 DCs included some potentially involved in
protein folding during antigen processing (clathrin and Rab-7), whilst other non-membrane
proteins such as enzymes/transporters related to cellmetabolism (malate dehydrogenase, py-
ruvate kinase, and ATPase Na+/K+) were also recorded. This suggests that pro-Th2 DCs are
moremetabolically activewhile pro-Th1 DCs have amature ‘end state’. Overall, although sev-
eralmoleculeswere preferentially expressed on pro-Th2DCs, our proteomics data support the
view of a ‘limited maturation’ of pro-Th2 DCs compared to pro-Th1 DCs.
Crown Copyright © 2011 Published by Elsevier B.V. All rights reserved.Keywords:
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brane leading to subsequent activation and maturation of the
DCs. Conversely, molecules from helminths, which are potent
inducers of Th2-type responses, stimulateDCswith a ‘modified’
phenotype [3–7] but it is unclear how/why these DCs promote
Th2-type immunity. Pro-Th2 DCs may have a distinct pheno-
type, defined by a unique profile of signature molecules [4,5],
or may resemble immature DCs, stimulating Th2 polarisation
via a ‘default’ pathway in the absence of Th1-inducing stimuli
[8]. An ‘inhibition model’ in which Th2-stimuli inhibit Th1
polarisation by DCs through competitive signalling pathways
has also been proposed [9].
Changes in DC gene expression correlate poorly with
changes in the level of protein expression [10,11]. Therefore, as
protein expression is a better indicator of cell phenotype and
function, a number of studies have examined the proteomes
of differentially matured DCs [12–15]. For example, 2-DE and
MS/MS have revealed changes in the proteome of pro-Th1 DCs
matured with LPS versus pro-Th2 DCs stimulated with excreto-
ry/secretory (E/S)material fromaparasitic helminth Schistosoma
mansoni [14]. This E/S material, released by the parasite during
infection and known as ‘0–3hRP’, is an important stimulant of
innate immune cells in the skin [16,17] enablingDCs to promote
Th2 responses in vitro and in vivo [7]. Proteomic analysis of pro-
Th1 DCs revealed up-regulated expression of cytoskeletal pro-
teins and chaperonemoleculeswhereas pro-Th2DCs, stimulat-
ed with 0–3hRP, exhibited a proteome intermediate between
that of immature DCs and pro-Th1 DCs; thus termed a ‘limited
maturation’ phenotype [14]. As soluble cytosolic molecules
dominated the cell extracts used in the study, immune-
associated proteins from the plasma membrane (e.g. PRRs, ad-
hesion molecules, MHC complexes and costimulatory mole-
cules) were not readily detected. Although such molecules are
likely to be highly relevant with respect to differential matura-
tion of DCs, their low abundance and hydrophobic nature
makes them difficult to isolate for proteomic characterisation.
In order to ‘home in’ on the detection of specific plasma
membraneproteinswhichare likely to be important in differen-
tial DC maturation, we compared proteins enriched from plas-
ma membranes of immature DCs, pro-Th1 DCs stimulated
with LPS and pro-Th2 DCs stimulated with schistosome egg an-
tigen (SEA) which is a well characterised pro-Th2 helminth
product [3]. First, DC plasma membrane-enriched fractions
were analysed by shotgun LC–MS/MS to establish a list of pro-
teins associated with DCs. Second, a gel-free technique using
iTRAQ [18,19] was used to quantify changes in protein expres-
sion following differential DC maturation. By performing three
biological replicates of each type of DCs and confirming proteo-
mic data by flow cytometry, we identified a number of proteins
that were differentially expressed by pro-Th1 versus pro-Th2
DCs.2. Materials and methods
2.1. Generation and maturation of DCs from bone marrow
Bone marrow-derived dendritic cells (BM-DCs) from female
C57BL/6 strain mice were cultured in RPMI medium containing
10% low endotoxin FCS plus 20 ng/mL GM-CSF (Peprotech,London, UK) as previously described [7,14]. All experimental
procedures were undertaken with the guidelines of the United
KingdomAnimal's Scientific Procedures Act 1986 and approved
by the University of York Ethics committee. On day 6, immature
BM-DCs were seeded at 1×106/mL and cultured for 18 h
alone (MED-DCs), or in the presence of 40 μg/mL SEA [3]
(SEA-DCs), or 10 ng/mL LPS (from Escherichia coli strain 0111:B4,
Sigma-Aldrich, Poole, UK; LPS-DCs) [14]. After overnight culture,
cells were harvested and prepared for proteomic analysis.
2.2. Preparation of DC plasma membrane-enriched
fractions
Plasma membrane proteins from MED-DCs, SEA-DCs and
LPS-DCs were extracted andpurifiedusing a plasmamembrane
protein extraction kit (BioVision,Mountain View, USA). All steps
were performed at 4 °C. Briefly, BM-DCs were mechanically
homogenised in an ice-cold glass cell grinder and then spun at
700 g. The resulting supernatants were spun at 10,000 g for
30 min to yield total membrane protein (i.e. plasma and cellular
organelle membranes) enriched pellets which were re-
suspended in ‘Upper Phase solution’ and mixed with an equal
volume of ‘Lower Phase solution’ before centrifugation at
1000×g for 5 min. The upper phase was spun at 25,000 g for
10 min, and the resulting plasma membrane-enriched pellet
solubilised in 0.5% Triton X-100. Total protein content was
assessed by densitometry of SYPRO Ruby stained 1-D electro-
phoresis gels (NuPAGE 4–12%) against knownquantities of cyto-
solic fractions as standards separated on the same gel.
2.3. Digestion and iTRAQ labelling
Plasma membrane-enriched fractions (35–50 μg) were reduced
with 2 mM tris-(2-carboxyethyl)phosphine in 0.5 M triethylam-
monium bicarbonate (Sigma-Aldrich) pH8.5, at 60 °C for 1 h,
alkylatedwith 10 mMmethylmethanethiosulfonate (Sigma-Al-
drich) at room temperature for 10min and digested overnight
with sequencing-grade porcine trypsin (Promega, Madison,
USA) at 37 °C. The iTRAQ labelling reagents (114, 115, and 116;
Applied Biosystems, Framingham, USA) were reconstituted in
isopropanol and added to the digests. After 2 h, labelled pep-
tides were combined and purified using cation-exchange and
C18 cartridges. Although iTRAQ allows for the multiplexing of
several samples in a single run, comparison is performed in a
pair-wise manner. In this respect, a common reference sample
between iTRAQ analyses is essential. However, a pooled stan-
dard is not universally required if the samples are suitably sim-
ilar, as in our study, where MED-DC is taken as a common
standard across all runs [20].
2.4. LC–MS/MS
Peptides were separated using a Dionex polystyrene-
divinylbenzene column and fractions collected directly onto a
target plate with addition of CHCA matrix. Positive-ion MALDI
mass spectra were acquired using an Applied Biosystems 4700
Proteomics Analyzer in reflectron mode over a mass range of
m/z 800–4000. Monoisotopic masses were obtained from cen-
troids of raw, unsmoothed data. The 20 most intense peaks
with a S/N≥50 from each fraction were selected for CID-MS/MS
940 J O U R N A L O F P R O T E O M I C S 7 5 ( 2 0 1 2 ) 9 3 8 – 9 4 8using collision energy of 1 keV, air as collision gas, precursor
mass window set to a relative resolution of 50 and metastable
suppressor enabled. MS/MS spectra were baseline-subtracted
(peak width 50) and smoothed (Savitsky–Golay; three points;
polynomial order 4); peak detection used S/N≥5, local noise
window 50m/z and minimum peak width 2.9 bins. Mascot
peak list files were generated using the TS2Mascot utility
(Matrix Science, version 1.0.0) with S/N≥10.
2.5. Protein identification and quantification
Peak lists were searched against the CDS (Celera Discovery Sys-
tem™, KBMS3.0.20040121) mouse database (65,307 sequences;
23,201,165 residues) using Mascot (Matrix Science Ltd., version
2.1). Search criteria specified: Enzyme, Trypsin; Maximum
missed cleavages, 1; Fixed modifications, Methylthio (C); Vari-
able modifications, Oxidation (M); Peptide tolerance, 0.3 Da;
MS/MS tolerance, 0.3 Da; Instrument, MALDI-TOF-TOF. When
searching iTRAQ peak lists the fixedmodifications, iTRAQ4plex
(N-term) and iTRAQ4plex (K), and the variable modification
iTRAQ4plex (Y), were also specified. The Mascot significance
threshold for protein identificationwas adjusted in each search
to give a false discovery rate of approximately 1%. Only peptides
that met or exceeded their identity score at this significance
threshold and had an expect score less than 0.05were accepted,
including single-peptide protein matches. Where peptides
match to multiple members of a protein family, the protein
that tops the Mascot protein group and hence has the highest
number of unique peptides, is reported. Mascot was used for
iTRAQ quantification with these options: normalisation by me-
dian ratio; automatic outlier removal; median ratios for protein
ratios. Fold changes were accepted only with three peptides.
Each iTRAQ experiment included three biological replicates.
2.6. Sub-cellular and Gene Ontology classification of proteins
Sub-cellular classificationswere performedwith GeneOntology
classification (http://www.ebi.ac.uk/GOA/) according to the ac-
cession number of protein identities in Uniprot. If no classifica-
tion was found, Mouse Genome Informatics website (http://
www.informatics.jax.org/) and the Proteome Analyst v3.0
(http://pa.cs.ualberta.ca:8080/pa/) were used. Finally, if no pre-
diction was available, we referred to published literature. Pro-
teins identified as ‘plasma membrane’ included formations
such as lipid rafts, endosomes, phagocytic cups and phago-
somes. ‘Cytosol’ comprised cytosolic, cytoplasmic proteins
and vesicles. Cytoskeletal proteins were given a particular col-
umn although most are also cytosolic. Ribosome proteins were
classified as belonging to the ‘ER’, whilst proteins associated
with the Golgi apparatus, late endosomes and lysosomes,
were defined as ‘Golgi’. However, classification of proteins into
discrete compartments is arbitrary depending upon original
allocation by bio-informatic interrogation andmay be best allo-
cated tomore than one classification. Protein hits that were ob-
served to be differentially regulated (i.e. SEA-DCs vs MED-DCs,
and LPS-DCs vs MED-DCs) were analysed according to Gene
Ontology (GO) classification using Visual Annotation Display
(VLAD; proto.informatics.jax.org/prototypes/vlad-1.0.3/). Signif-
icant hits were selected on the basis of their p-value and the
number of proteins(k) found within each category.2.7. Validation of protein expression by flow cytometry
Differentially matured DCs were blocked with anti-CD16/32
mAb (BD Pharmingen, Oxford, UK) in PBS (supplemented with
1% FCS and 5mMEDTA) and subsequently labelledwith the fol-
lowing conjugated mAbs against: CD18-biotin (M18/2), CD29-PE
(HMb1-1), CD44-FITC (1C10), CD98-FITC (RL388), IA/IE-FITC (M5/
114.15.2), Galectin-3-biotin (M3/38; all from eBioscience,
Hatfield, UK), I-Ab biotin (28-16-8S; Caltag Medsystems,
Buckingham, UK) and CD301b-AF647 (ER-MP23; AbD Serotec,
Kidlington, UK). Biotin conjugated antibodies were probed
with streptavidin-APC (Caltag Medsystems). Unlabelled rabbit
polyclonal antibodies were used to probe for S100A10 (Abcam,
Cambridge, UK), YM-1 (STEMCELL Technologies, Grenoble,
France) and Rab-7 (Sigma-Aldrich), and were subsequently
detectedwith anti-rabbit AF488 antibody (eBioscience). All anti-
body concentrations were optimised and labelling was per-
formed alongside relevant isotype controls. Flow cytometric
acquisition and analysis was performed using a Cyan ADP ana-
lyser with Summit v4.3 (DakoCytomation, UK). Data were plot-
ted as means of the median fluorescence intensity (MFI) of
three separate DC cultures for each maturation stimulus.3. Results
3.1. Sub-cellular classification of proteins identified by
shotgun LC–MS/MS
Initial shotgun LC–MS/MS proteomic analyses of DC frac-
tions were performed to validate the isolation technique. In
MED-DCs, 119 significant hits were identified (Supp. Table 1)
of which 37% were classified by Gene Ontology as plasma
membrane (Fig. 1A). In SEA-DCs and LPS-DCs, 149 and 61 pro-
teins respectively were identified (Supp. Tables 2 and 3) with
32% and 52% from the plasma membrane (Fig. 1A). The frac-
tions also contained cytosolic (19%), cytoskeletal (15%) and
nuclear proteins whilst extracellular, ER and Golgi proteins
were only minor components. In six different purification ex-
periments, the enrichment for plasma membrane proteins in
the fractions, compared to the total cell, was 23.4±3.1. Conse-
quently, we concluded that the isolation technique yielded
fractions greatly enriched in plasma membrane molecules.
Plasma membrane molecules (shaded rows in bold text of
Supp. Tables 1, 2, and 3) comprised those with a CD prefix
(18%) and ras-related proteins (rho, rac, rab and rap; 17%)
which were highly represented from all three types of DC.
Other abundant molecules were MHC class I and II molecules
for LPS-DCs (13%) and guanine nucleotide-binding proteins
(GNBPs) in MED-DCs (11%). Annexins (1, 2, 4 and 5) and S100
proteins represented 10% and 5% respectively, of plasma
membrane proteomes of all DC types.
3.2. Plasma membrane proteomes of differentially matured
DCs after iTRAQ labelling
The number of hits identified after iTRAQ labelling in SEA-
DCs versus MED-DCs, and LPS-DCs versus MED-DCs increased
compared to the number of hits in SEA-DCs and LPS-DCs iden-
tified solely by LC–MS/MS (+66% and +46% respectively; Supp.
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Fig. 1 – Sub-cellular classification of the total identified proteins. Pie-charts showing the classification of total protein identities
in plasma membrane fractions obtained from MED-DCs, SEA-DCs and LPS-DCs determined by LC–MS/MS (A). Pie-charts
showing the classification of the total hits obtained from three technical replicates of iTRAQ experiments comparing SEA-DCs
or LPS-DCs versus MED-DCs (B).
941J O U R N A L O F P R O T E O M I C S 7 5 ( 2 0 1 2 ) 9 3 8 – 9 4 8Tables 4, 5 versus 1, 2, 3). This resulted in expanded DC prote-
ome coverage and database searching of multiple peptides
per protein improved the confidence of the identifications.
Nevertheless, the proportion of hits identified after iTRAQ la-
belling and classed as plasma membrane were similar to that
revealed by shotgun LC–MS/MS.
Compilation of hits identified in the three separate iTRAQ
experiments of SEA-DCs versus MED-DCs showed that 222
proteins were significantly identified with 45% being classed
as plasma membrane components (Fig. 1B, Supp. Table 4)
while a similar proportion (44%) was identified in LPS-DCs ver-
susMED-DCs (Fig. 1B, Supp. Table 5). Overall, a greater propor-
tion of hits were identified as nuclear proteins in SEA-DCs
versus MED-DCs (18%) compared to LPS-DCs versus MED-DCs
(8%) whereas a greater proportion of proteins in LPS-DCs ver-
sus MED-DCs were mitochondrial, extracellular and associat-
ed with the Golgi apparatus.3.3. Up- or down-regulated proteins from differentially
matured DC membrane-enriched proteomes
In order to assess variance in iTRAQ quantification experi-
ments, Spooncer et al. [21] devised a form of analysis to com-
pare separate preparations of the same biological material
[22]. Ratios obtained by comparing separate preparations of
the same material plotted against the number of peptides
identified (Fig. 2) should cluster around unity (i.e. protein
levels should be the same between replicates). The extent to
which values deviate from unity is an indication of the biolog-
ical and technical variance. This approach provided a power-
ful visual indication of where to set the significance threshold.
Our iTRAQ experimental design consisted of six label-
ling experiments (Table 1), in which three preparations of
SEA-DCs and three preparations of LPS-DCs were analysed.
MED-DC fractions were labelled with 114 and 116 iTRAQ
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Fig. 2 – Whetton's plot. iTRAQ reporter-ion ratios for all proteins in the control versus control comparisons using the 114 and
116 reagents. A total of 355 protein ratios were plotted against the number of peptides that contributed to the ratio. Shading
zones represent two levels of threshold: at log(ratio) values of ±0.1 (ratios 0.79–1.26 in mid-grey) and a less stringent threshold
of ±0.04 (ratios 0.9–1.1 in light grey).
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LPS-DC preparations were labelled with 115. All the protein
ratios from the six control–control (114:116) comparisons
(355 in total) are shown in Fig. 2. As a more stringent thresh-
old, we chose log(ratio) values of ±0.1, which correspond to
ratios of 1.26 and 0.79; a less stringent threshold of ±0.04,
which correspond to ratios of 1.1 and 0.9 was also used.
Only changes where the average log(ratio) ±SEM-95%
exceeded these thresholds were considered significant as
given for SEA-DCs versus MED-DCs (Fig. 3, Supp. Table 6)
and LPS-DCs versus MED-DCs (Fig. 4, Supp. Table 7). The
more stringent threshold is shown as shaded bars and rows.
In SEA-DCs versus MED-DCs, the greatest up-regulation
was for nuclear proteins (mainly histones) while several pro-
teins associated with antigen uptake, processing and presen-
tation (chaperones, clathrin, enzymes and the small GTPase
Rab-7) were also up-regulated (Fig. 3, Supp. Table 6). Other
molecules which were significantly up-regulated included:
S100A9, 14-3-3β/α (part of TGFβ family), lymphocyte cytosolic
protein 1 and lysozyme C. In contrast, decreased expression
was observed for FcεRI, Rap-1B, hematopoietic cell specific
lyn substrate 1, CD44, several annexins, MHC class II molecule
(I-A), subunit 2 of actin-related protein 2/3 (Arp2/3) complex,
lymphocyte-specific 1 protein (LSP1) and S100A10 (Fig. 3,
Supp. Table 6). Down-regulation was also recorded for certain
cytoskeletal proteins (ezrin, moesin, myosin and several iso-
forms of actin). Themost pronounced down-regulation affect-
ed a protein not expected to be expressed by DCs: NAP-22
(22 kDa neuronal tissue-enriched acidic protein). Finally, sev-
eral immune-related proteins were expressed at similar levels
between SEA-DCs andMED-DCs (Fig. 3) including the integrins
CD11b and CD18, the macrophage lectin CD301b, CD98
heavy chain, CD45, as well as MHC class I molecules (H-2Db
and H-2Kb) and their associated β2-microglobulin. Also
expressed at similar levels was the subunit 4 of Arp2/3 com-
plex, proteins involved in general cell metabolism and the
ras-related proteins Rac-1, -2, -3 together with cdc42.
Several proteins were highly up-regulated in LPS-DCs versus
MED-DCs (Fig. 4, Supp. Table 7) includingMHCclass IImolecules(IA-α representing the highest increase), CD98 heavy chain,
β2-microglobulin and transgelin 2. Intriguingly, NAP-22 was
up-regulated in LPS-DCs versus MED-DCs (it was down-
regulated in SEA-DCs versus MED-DCs). The integrin CD29
(β subunit of VLA-4) was also up-regulated but not identified
between SEA-DCs versus MED-DCs. Down-regulation affect-
ed S100A10, moesin and CD44, as also reported for SEA-DCs
versus MED-DCs. Additionally, we observed specific de-
creased expression of CD18, both chains of ATP synthase
and the precursor of cathepsin D. Significantly, expression
of the secretory protein YM-1, associated with ‘alternative-
ly-activated’ macrophages, was also highly down-regulated
in LPS-DCs versus MED-DCs. Proteins whose expression was
unchanged between LPS-DCs versus MED-DCs were GAPDH,
several ras-related proteins (including Rab-7), several actin
isoforms and galectin-3.
Analysis of protein classification according to GO terms
revealed that SEA-DCs had numerous (k=17) up-regulated pro-
teins related to cellular metabolism, in particular Nucleoside
phosphate metabolic processing (Table 2). These cells also
exhibited up-regulated proteins associated with cytoskeleton
remodelling specifically a number linked to the formation of
cell projections (k=13). On the other hand, SEA-DCs had
down-regulatedproteins associatedwith responses to chemical
stimulation (k=10) and GTPase activity (k=5). Interestingly,
down-regulated protein hits also mapped to those associated
with antigen processing, and regulation of the adaptive im-
mune response. In contrast, up-regulated proteins in LPS-DCs
mapped clearly to antigen presentation and the MHC protein
complex, whilst down-regulated proteins were associated with
transmembrane transporter activity, catabolic processes and
responses to wound healing (all k=3).
3.4. Extrapolated changes between pro-Th2 DCs and pro-
Th1 DCs
As we could not directly compare SEA-DCs versus LPS-DCs
(due to the constraints of the availability of only 3 iTRAQ la-
bels), we made an extrapolation of the above data in order to
Fig. 3 – Changes on plasma membrane enriched-proteome of SEA-DCs versus MED-DCs. Up- and down-regulation of DC
proteins as average log(ratio)±standard error-95%, obtained from three iTRAQ experiments with criteria for acceptance clearly
stated in the Results section.
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and pro-Th1 DCs (Table 3). Amongst the proteins identified
both in SEA-DCs versus MED-DCs and LPS-DCs versus
MED-DCs, moesin, CD18, CD44 and Rab-7 were increased in
SEA-DCs compared to LPS-DCs. Conversely, transgelin 2,
NAP-22, MHC class II, annexin A1 and A4, β2-microglobulin,
S100A10 protein, two actin isoforms and Rap-1b were down-
regulated. The only protein similarly expressed by both
types of differentially matured DCs was GAPDH.3.5. Validation of protein expression by flow cytometry
Several proteins identified by our iTRAQ studies, for which
commercially available antibodies are available, were validat-
ed for changes in expression by flow cytometry (Fig. 5).
The MHC class II molecules IA-b and IA/IE were both signifi-
cantly up-regulated on LPS-DCs compared to SEA-DCs and
MED-DCs, confirming the changes in expression recorded
using iTRAQ. CD29 and S100A10 were also up-regulated on
Table 1 – Experimental design for iTRAQ. Summary of the
six experiments comparing plasma membrane proteins
from separate cultures of DCs grown in medium only
(MED #1–6), or stimulated with SEA (SEA #1–3) or LPS (LPS
# 1–3).
iTRAQ Label
Expt # 114 115 116
1 MED-1 SEA-1 MED-1
2 MED-2 SEA-2 MED-2
3 MED-3 SEA-3 MED-3
4 MED-4 LPS-1 MED-4
5 MED-5 LPS-2 MED-5
6 MED-6 LPS-3 MED-6
944 J O U R N A L O F P R O T E O M I C S 7 5 ( 2 0 1 2 ) 9 3 8 – 9 4 8LPS-DCs but down-regulated in SEA-DCs, mirroring proteomic
analysis. Whilst CD98 was up-regulated in both LPS-DCs and
SEA-DCs compared to MED-DCs, CD18 was only up-regulated
in SEA-DCs and was more abundant than in LPS-DCs. CD44
was expressed at higher levels in SEA-DCs than LPS-DCs.
Several molecules were expressed at similar levels in all
three types of DCs (i.e. galectin-3 and CD301b) corroborating
proteomic analysis, although the expression of Rab-7 which
was elevated at the proteomic level in SEA-DCs compared to
LPS-DCs, was not differentially expressed as judged by flow
cytometry. Finally, the secretory molecule YM-1, which was
significantly down-regulated in LPS-DC versus MED-DC as de-
termined by iTRAQ, was also down-regulated as judged by
flow cytometry, although it was detected at slightly lower
levels in SEA-DCs compared to MED-DCs.4. Discussion
Over thepast decade, proteomicshas beenutilised todetermine
differences between various immune cells [23] and in particular
to study differences betweenwhole cell extracts from immature
DCs and differentially matured DCs with various PAMPs [24].
Mainly, these studies have employed 2-DE-based proteomics-0.50 -0.40 -0.30 -0.20 -0.10 -0.00
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proteins as average log (ratio)±standard error-95%, obtained from
stated in the Results section.and highlighted changes in the expression of cytoskeletal and
cytoplasmic molecules needed for basic cellular functions
[12–14,25]. Such an approach favours soluble and abundant cy-
tosolic proteins but compromises the detection of scarcer and
detergent-soluble proteins, such as those present in plasma
membranes. In the present study, we focussed upon the pro-
teomes of plasmamembrane-enriched fractions of differential-
ly matured DCs. Although the fractions isolated were relatively
crude, they were clearly enriched in plasmamembrane compo-
nents (~30–50%).
Indeed, LC–MS/MS has several advantages in the analysis
of plasma membrane components. First, it requires only low
amounts of any given protein for MS analyses, so is suitable
for scarcer proteins. Second, digestion of enriched mem-
branes can be performed in the presence of trace amounts of
ionic detergents which, along with the use of reducing and
alkylating reagents, allows for improved trypsin cleavage
leading to higher sequence coverage for a given protein.
Furthermore, labelling peptides with iTRAQ tags prior to
LC–MS/MS allows the relative amounts of a protein to be de-
termined in different cell groups, which is difficult to be ac-
curately demonstrated by ‘label-free’ LC–MS/MS.
As revealed by our ‘label-free’ shotgun proteomics and
found in all three types of DCs, the most abundant molecules
associated with the plasma membrane including those with a
CD prefix, ras-related proteins, MHC molecules and GNBPs.
Others included proteins associated with membrane and ves-
icle trafficking such as the calcium-sensitive annexins [26]
and phagocyte-specific S100 calcium binding proteins which
are major damage associated molecular patterns [27]. The
three differentially matured DCs also all expressed lympho-
cyte cytosolic protein 1 (also called 65 kDa macrophage pro-
tein), LSP-1 (F-actin binding protein) and FcεRI, although
various immune associated proteins were only found in one
or two of the DC types. For instance, immature MED-DCs and
pro-Th2 SEA-DCs both expressed CD11b, CD44, CD45 and
CD48, while both pro-Th2 DCs and pro-Th1 DCs expressed
the heavy chain of CD98 which is involved in activation of
naive and memory CD4 and CD8 T cells [28], thereby arguing
against the ‘default’ hypothesis of pro-Th2 DCs.0.10 0.20 0.30 0.40 0.50
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Fig. 5 – Validation of protein expression on DCs judged by flow cytometry of antibody labelled cells. Various molecules
expressed by DCs were quantified by flow cytometry of antibody labelled cells. Bars are means of MFI values of three separate
cultures for each type of differentially matured DC. Significant differences of SEA-DCs and LPS-DCs compared to MED-DCs as
**p<0.01 and *p<0.05.
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comparison and quantification of changes in the plasma
membrane proteome, many of which being confirmed by
flow cytometry. As our study compared three biological repli-
cates of each type of DCs, we were able to determine whether
changes in the level of protein expression were reproducible.
Our study revealed significantly increased levels of MHC
class II molecules in pro-Th1 DCs, which were unchanged or
decreased in pro-Th2 DCs. Surprisingly, CD29 which mediates
the interaction of immature DCs with extracellular matrix
components, and thus with a likely role in the retention of
DCs in the periphery [29,30], was also highly expressed by
LPS-DCs versus immature DCs. Conversely, pro-Th2 SEA-DCs
expressed increased levels of proteins like CD18 and CD44.The greatest decrease of any protein expressed in pro-Th2
SEA-DCs was for NAP-22 (also called BASP-1 or CAP-23) where-
as it was greatly up-regulated on pro-Th1 DCs. This molecule
was originally identified as a membrane/cytoskeletal protein
from rat brain and is a member of a family of motility associ-
ated proteins linked to actin reorganisation and neurite devel-
opment [31,32]. Recently, it has been defined in the context of
blocking oncogenic Myc protein-induced cell transformation
[33]. Although this molecule was not expected to be expressed
by DCs, and has not previously been identified as having de-
monstrable immune function, its differential distribution be-
tween pro-Th1 versus pro-Th2 is intriguing and warrants
further investigation. One of the most down-regulated mole-
cules in pro-Th1 LPS-DCs versus MED-DCs was YM-1 as
Table 2 – Analysis of differentially regulated proteins according to Gene Ontology term. Proteins were analysed for GO term
enrichment and presented as up-regulated (top panel), or down-regulated (bottom panel) for SEA-DCs and LPS-DCs.
Significance is given as p-value, whilst the number of different proteins identified within a given classification is presented
as k.
SEA-DCs versus MED-DCs LPS-DCs versus MED-DCs
Up-regulated Up-regulated
GO term p-value k GO term p-value k
Cell projection GO:0042995 1.49E−11 13 Antigen processing and presentation
of exogenous peptide antigen
GO:0002478 1.27E−08 3
Purine ribonucleoside triphosphate
binding
GO:0035639 1.34E−06 10 MHC protein complex GO:0042611 1.67E−08 3
Metabolic process GO:0008152 5.52E−05 17 Peptide antigen binding GO:0042605 5.42E−06 2
Nucleoside phosphate metabolic
process
GO:0006753 6.53E−05 5 Cellular developmental process GO:0048869 9.77E−04 4
Down-regulated Down-regulated
GO term p-value k GO term p-value k
Response to chemical stimulus GO:0042221 8.38E−07 10 Active transmembrane transporter
activity
GO:0022804 6.49E−05 3
GTPase activity GO:0003924 2.02E−07 5 Catabolic process GO:0009056 2.92E−04 4
Antigen processing and presentation of
exogenous peptide antigen via MHC class II
GO:0019886 5.49E−05 2 Response to wounding GO:0009611: 2.12E−04 3
Regulation of adaptive immune response GO:0002819 6.44E−05 3
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cytometry. This molecule has been associated with the de-
velopment of ‘alternatively-activated’ macrophages and
the recruitment of eosinophils [34], particularly after
multiple exposure to schistosome cercariae [35] and other
helminth infections which induce Th2-type immune re-
sponses [36,37].
A number of other changes in protein expression may help
explain the differential DC phenotype/function. For example,
SEA-DCs may be more efficient at antigen uptake and proces-
sing than immature MED-DCs as several chaperone proteins
and enzymes involved in protein folding were up-regulated in
pro-Th2 DCs compared to immature DCs (i.e. HSP-90α, two iso-
forms of hsc71, clathrin and Rab-7) although flow cytometry
analysis revealed intracellular Rab-7 expressionwas similar be-
tween pro-Th2 DCs and pro-Th1 DCs. Another molecule up-
regulated in SEA-DCs was protein disulfide isomerase which
not only participates in the editing ofMHC class I peptide reper-
toire [38] but also inhibits the transcriptional activity of NF-κB as
a downstream signal of IL-10 [39]. In contrast, most of the pro-
teins reported above were not identified in mature pro-Th1
DCs that have lost their capacity to take up and process antigen,
however they are poised to present antigens, as suggested by
our GO term enrichment analysis. Moreover, many enzymes
and transporters related to general cell metabolism (i.e.malate
dehydrogenase, pyruvate kinase 3, arginosuccinate synthase,
fructose-bisphosphate aldolase A, enolase 1 and two chains of
transporting ATPase Na+/K+) were up-regulated, or expressed
at similar levels, between SEA-DCs versus MED-DCs, while
their expression was mostly decreased in LPS-DCs versus
MED-DCs. This suggests that MED-DCs and pro-Th2 DCs are
more metabolically active compared to pro-Th1 LPS-DCs that
have matured into an ‘end state’. GO term enrichment analysis
confirmed that pro-Th2 DCs up-regulated proteins associatedwith nucleotide metabolism, whilst at the same time had
down-regulated responses to chemical stimulus and regulation
of the adaptive immune response.
Many of the proteomic changes in pro-Th2 SEA-DCs affect-
ed cytoskeletal proteins confirming previous studies using
2-DE-based proteomics [14]. For example, vimentin, tubulin
β5, non-muscle myosin, talin and coactosin-like protein
were all up-regulated in SEA-DCs, whereas proteins associ-
ated to actin such as Arp2/3 with a role in membrane traf-
ficking [40] and ezrin–radixin–moesin complex that links
cytoskeletal components with plasma membrane proteins
[41] were down-regulated versus MED-DCs. Moreover, in
LPS-DCs few cytoskeletal proteins were identified, alterna-
tively they were down-regulated or expressed at similar
levels compared to MED-DCs (i.e. actin isoforms, destrin and
moesin). Finally, our study also reveals that SEA-DCs contain
twice as many nuclear proteins than LPS-DCs or immature
DCs. These proteins include initiation and elongation factors,
several histones, signalling proteins (MAPK3, Erk-1) indicating
that SEA may be a potent stimulus for DC proliferation.
Our study using iTRAQ labelling combined with LC–MS–MS
has provided a valuable appraisal of the repertoire of proteins
expressed by differentially matured DCs particularly within
the plasma membrane. This offered new insights into how
differentially matured DCs may function to promote Th1 or
Th2 polarisation of the adaptive immune response. A caveat
to studies using bone-marrow derived DCs is that whilst the
cells have a high level of purity and are of immature/neutral
status, they may not be representative of DCs from tissues in
vivo which are subject to many local factors, such as the
local cytokine environment [35], which influence their matu-
ration as pro-Th1 versus pro-Th2 DCs. However, we believe
that our combined approach has the potential to reveal the
identity of further molecules involved in DC differentiation,
Table 3 – Extrapolated proteins changes between SEA-DCs and LPS-DCs. List of proteins present both in Table 1 (SEA-DCs
versus MED-DCs) and Table 2 (LPS-DCs versusMED-DCs) with their respective average log(ratio): (1) and (2). The extrapolated
average log(ratio) for pro-Th2 SEA-DCs compared to pro-Th1 LPS-DCs equals (1)–(2). Shaded rowshighlightedmajor changes at
themost stringent threshold: log(ratio) values of ±0.1. The table presents the proteins from themost up-regulated at the top to
the most down-regulated at the bottom. The accession numbers were the ones given by the Mascot search against the CDS
mouse database.
Accession no. SEA versus
MED
LPS versus
MED
SEA versus
LPS
Protein hits
Up-regulation
/:spt|P26041| −0.079 −0.334 0.255 Moesin (Membrane-organising extension spike protein)
/:trm|Q80X37| −0.078 −0.285 0.207 CD44
/:pir|S04847| −0.021 −0.129 0.108 CD18, Integrin β-2 precursor (LFA-1/CR3/P150,95 β-subunit)
/:dbj|BAB23738.1| 0.072 −0.037 0.108 Ras-related protein Rab-7
No change
/:spt|P16858| 0.017 −0.023 0.040 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
Down-regulation
/:rf|NP_077777.1| −0.062 0.021 −0.082 Ras-related protein Rap-1B
/:trm|Q9CXK3| −0.107 −0.017 −0.090 Actin, α, cardiac
/:rf|NP_031419.1| −0.112 −0.014 −0.098 Actin, β, cytoplasmic
/:spt|P08207| −0.155 −0.048 −0.107 S100 A10, calpactin I light chain
/:pdb|1BZ9_B| −0.040 0.067 −0.107 β-2-microglobulin precursor
/:trm|Q7TMN7| −0.038 0.086 −0.124 Annexin A4
/:spt|P10107| −0.098 0.031 −0.128 Annexin A1, calpactin II
/:trm|Q9TP17| −0.107 0.159 −0.266 H-2 class II histocompatibility antigen, A β chain precursor (I-A)
/:trm|Q91XV3| −0.208 0.078 −0.286 22 kDa neuronal tissue-enriched acidic protein, NAP-22, BASP-1
/:trm|Q91VU2| −0.062 0.269 −0.331 ~ transgelin 2 (SM22β)
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to higher sensitivity mass spectrometry instrumentation is
employed. Accordingly, Segura et al. [42] recently reported
an extensive comparative list of membrane proteins from
immunopurified DCs using 2D liquid peptide fractionation fol-
lowed by MS/MS in an Orbitrap instrument. However, their
analysis was performed using only a single biological sample
and protein expression was inferred by spectral counting.
Their study also did not examine differential maturation
after stimulation of DCs with different PAMPs.
In conclusion, our study and resulting analysis of the pro-
teomic data support the view of a ‘limited maturation’ of
pro-Th2 DCs compared to pro-Th1 DCs. We also report evi-
dence of the expression of a restricted number of membrane
proteins which may be unexpected ‘signatures’ of pro-Th2
DCs and consequently warrant further investigation.
Supplementary materials related to this article can be
found online at doi:10.1016/j.jprot.2011.10.010.Acknowledgements
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